These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16572411)

  • 1. Breast cancer incidence after the introduction of mammography screening: what should be expected?
    Svendsen AL; Olsen AH; von Euler-Chelpin M; Lynge E
    Cancer; 2006 May; 106(9):1883-90. PubMed ID: 16572411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimates of overdiagnosis of invasive breast cancer associated with screening mammography.
    Morrell S; Barratt A; Irwig L; Howard K; Biesheuvel C; Armstrong B
    Cancer Causes Control; 2010 Feb; 21(2):275-82. PubMed ID: 19894130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
    Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years.
    Taylor R; Page A; Bampton D; Estoesta J; Rickard M
    J Med Screen; 2004; 11(4):199-206. PubMed ID: 15563775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seventeen-years overview of breast cancer inside and outside screening in Denmark.
    Domingo L; Jacobsen KK; von Euler-Chelpin M; Vejborg I; Schwartz W; Sala M; Lynge E
    Acta Oncol; 2013 Jan; 52(1):48-56. PubMed ID: 22943386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer incidence and mortality in the Nordic capitals, 1970-1998. Trends related to mammography screening programmes.
    Törnberg S; Kemetli L; Lynge E; Helene Olsen A; Hofvind S; Wang H; Anttila A; Hakama M; Nyström L
    Acta Oncol; 2006; 45(5):528-35. PubMed ID: 16864165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].
    Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P
    Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations.
    Verkooijen HM; Koot VC; Fioretta G; van der Heiden M; Schipper ME; Rapiti E; Peeters PH; Peterse JL; Bouchardy C
    Breast Cancer Res Treat; 2008 Feb; 107(3):389-95. PubMed ID: 17431760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nationwide breast cancer screening fully accomplished; results from the implementation phase 1990-1997. National Evaluation Team for Breast Cancer Screening].
    Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1124-9. PubMed ID: 10876708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties.
    Duffy SW; Tabár L; Chen HH; Holmqvist M; Yen MF; Abdsalah S; Epstein B; Frodis E; Ljungberg E; Hedborg-Melander C; Sundbom A; Tholin M; Wiege M; Akerlund A; Wu HM; Tung TS; Chiu YH; Chiu CP; Huang CC; Smith RA; Rosén M; Stenbeck M; Holmberg L
    Cancer; 2002 Aug; 95(3):458-69. PubMed ID: 12209737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of clinical breast examination to the accuracy of breast screening.
    Chiarelli AM; Majpruz V; Brown P; Thériault M; Shumak R; Mai V
    J Natl Cancer Inst; 2009 Sep; 101(18):1236-43. PubMed ID: 19720967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of primary breast cancer. Consequences of mammographic screening in the municipality of Copenhagen].
    Hirsch FR; Mouridsen HT; Hansen OP; Jørgensen T; Blichert-Toft M; Rank FE; Jensen MB
    Ugeskr Laeger; 1996 Feb; 158(9):1218-21. PubMed ID: 8644426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammography screening and the increase in breast cancer incidence in Hawaii.
    Maskarinec G; Wilkens L; Meng L
    Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):201-8. PubMed ID: 9138664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program.
    Olsen AH; Agbaje OF; Myles JP; Lynge E; Duffy SW
    Breast J; 2006; 12(4):338-42. PubMed ID: 16848843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer detection rates, and standardised detection ratios for prevalence screening in the New Zealand breast cancer screening programme.
    Richardson A; Graham P; Brown T; Smale P; Cox B
    J Med Screen; 2004; 11(2):65-9. PubMed ID: 15153320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes among women younger than age 40 in a state breast cancer screening program.
    Vetto JT; Wheeler AJ; Toomey M; Schmidt KJ
    Am J Surg; 2006 May; 191(5):635-40. PubMed ID: 16647351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.
    Kriege M; Brekelmans CT; Boetes C; Muller SH; Zonderland HM; Obdeijn IM; Manoliu RA; Kok T; Rutgers EJ; de Koning HJ; Klijn JG;
    Cancer; 2006 Jun; 106(11):2318-26. PubMed ID: 16615112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women.
    Jemal A; Ward E; Thun MJ
    Breast Cancer Res; 2007; 9(3):R28. PubMed ID: 17477859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cumulative risk of a false-positive recall in the Norwegian Breast Cancer Screening Program.
    Hofvind S; Thoresen S; Tretli S
    Cancer; 2004 Oct; 101(7):1501-7. PubMed ID: 15378474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.